爵士製藥JAZZ
那斯達克 · USD
114.63
-1.49
(-1.28%)
收盤 08/01 03:59 (UTC+8)
盤後
0
0
(0%)
08/01 03:59 (UTC+8)
爵士製藥JAZZ
114.63
-1.49
(-1.28%)
財務數據
損益表
- 9.72
- 8.93
- 9.57
- 9.72
- 10.12
- 9.02
- 10.24
- 10.55
- 10.88
- 8.98
- 3.35
- -8.16
- 7.22
- 1.55
- 4.09
- -10.87
- 13.51
- 3.04
- 3.15
- -17.49
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 897,841 | 1,088,173 | 1,054,969 | 1,023,825 | 901,983 | 1,011,935 | 972,140 | 957,317 | 892,812 | 972,123 |
營業成本 | 104,620 | 128,713 | 111,611 | 109,902 | 95,487 | 107,243 | 102,153 | 97,537 | 128,644 | 167,364 |
營業毛利 | 793,221 | 959,460 | 943,358 | 913,923 | 806,496 | 904,692 | 869,987 | 859,780 | 764,168 | 804,759 |
營業費用 | 849,113 | 768,690 | 683,148 | 714,480 | 740,289 | 782,195 | 697,595 | 702,144 | 638,113 | 1,068,145 |
研發費用 | 180,652 | 240,500 | 199,919 | 220,734 | 222,847 | 216,608 | 234,402 | 209,238 | 189,410 | 172,555 |
推銷及管理費用 | 514,013 | 369,287 | 325,772 | 338,523 | 351,712 | 396,034 | 308,310 | 340,844 | 297,917 | 383,203 |
非經常性項目費用 | - | - | - | - | 10,000 | 18,000 | - | - | 1,000 | 375,000 |
其他營業費用 | 154,448 | 158,903 | 157,457 | 155,223 | 155,730 | 151,553 | 154,883 | 152,062 | 149,786 | 137,387 |
營業利益 | -55,892 | 190,770 | 260,210 | 199,443 | 66,207 | 122,497 | 172,392 | 157,636 | 126,055 | -263,386 |
其他收入及費用 | -213 | -6,295 | -701 | 507 | -1,693 | 9,353 | -1,377 | -2,382 | 3,193 | -2,482 |
利息費用 | 53,706 | 51,256 | 58,702 | 62,023 | 66,116 | 70,324 | 71,497 | 73,470 | 74,147 | 74,125 |
稅前純益 | -109,811 | 133,219 | 200,807 | 137,927 | -1,602 | 61,526 | 99,518 | 81,784 | 55,101 | -339,993 |
所得稅 | -17,812 | -57,912 | -14,533 | -30,653 | 11,669 | -33,089 | -47,176 | -24,323 | -15,324 | -100,042 |
稅後純益 | -92,541 | 191,115 | 215,055 | 168,568 | -14,618 | 94,154 | 146,820 | 104,438 | 69,420 | -240,724 |
基本每股稅後盈餘(元) | -1.52 | 3.16 | 3.50 | 2.68 | -0.23 | 1.50 | 2.33 | 1.63 | 1.09 | -3.82 |
稀釋每股稅後盈餘(元) | -1.52 | 3.02 | 3.28 | 2.58 | -0.23 | 1.43 | 2.12 | 1.51 | 1.04 | -3.84 |
基本平均股數(千股) | 60979.00 | 60538.00 | 61414.00 | 62882.00 | 62537.00 | 62578.00 | 63114.00 | 63991.00 | 63494.00 | 63052.00 |
稀釋平均股數(千股) | 60979.00 | 61503.00 | 63174.00 | 69625.00 | 62537.00 | 69673.00 | 71293.00 | 73540.00 | 73771.00 | 63052.00 |
還原基本每股稅後盈餘(元) | -1.52 | 3.16 | 3.50 | 2.68 | -0.23 | 1.50 | 2.33 | 1.63 | 1.09 | -3.82 |
還原稀釋每股稅後盈餘(元) | -1.52 | 3.02 | 3.28 | 2.58 | -0.23 | 1.43 | 2.12 | 1.51 | 1.04 | -3.84 |
還原基本平均股數(千股) | 60,979 | 60,538 | 61,414 | 62,882 | 62,537 | 62,578 | 63,114 | 63,991 | 63,494 | 63,052 |
還原稀釋平均股數(千股) | 60,979 | 61,503 | 63,174 | 69,625 | 62,537 | 69,673 | 71,293 | 73,540 | 73,771 | 63,052 |
EBITDA(千元) | 108,226 | 352,876 | 424,456 | 362,973 | 226,550 | 290,590 | 333,699 | 313,162 | 285,603 | -121,910 |